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Summary: Sequencing-based studies are emerging as a major tool for genetic association studies of complex diseases. These
studies pose great challenges to the traditional statistical methods because of the high-dimensionality of data and the low
frequency of genetic variants. Moreover, there is a great interest in biology and epidemiology to identify genetic risk factors
contributed to multiple disease phenotypes. The multiple phenotypes can often follow different distributions, which brings an
additional challenge to the current statistical framework. In this paper, we propose a generalized similarity U test, referred
to as GSU. GSU is a similarity-based test that can handle high-dimensional genotypes and phenotypes. We studied the
theoretical properties of GSU, and provided the efficient p-value calculation for association test as well as the sample size
and power calculation for the study design. Through simulation, we found that GSU had advantages over existing methods
in terms of power and robustness to phenotype distributions. Finally, we used GSU to perform a multivariate analysis of
sequencing data in the Dallas Heart Study and identified a joint association of 4 genes with 5 metabolic related phenotypes.
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1. Introduction
Genome-wide association studies (GWAS) have made sub-
stantial progress in discovering common genetic variants
associated with complex diseases. Despite such success, a
large proportion of heritability of complex diseases remains
unexplained. Converging evidence has suggested that rare
variants with minor allele frequency (MAF) less than 5% or
1% hold promise in accounting for a significant proportion
of the missing heritability (Fay et al., 2001; Pritchard, 2001;
Kryukov et al., 2007; Boyko et al., 2008). With the advance of
next-generation sequencing (NGS) technology, we have now a
unique opportunity to investigate the role of a wider scope of
genetic variants, primarily rare variants, in human diseases.
Evidence in early sequencing studies have already shown that
rare variants played an important role in complex diseases
(Cohen et al., 2004; Ahituv et al., 2007; Ji et al., 2008; Romeo
et al., 2009). Although promising, the massive data generated
from sequencing studies poses great challenges on the statis-
tical methods. Rare mutations are recent mutations, and can
be only found in a small fraction of individuals in the entire
population. Even with a large effect size, a rare variant is hard
to be detected because of its low MAF. Moreover, the massive
number of rare variants raises the computational burden and
the multiple comparison issue. Therefore, traditional single-
locus analysis has low power to detect rare variants.
Many new statistical methods have been developed for the
sequencing data in the last few years. Different from the
traditional single-locus analysis, most of the new methods
perform a joint association test, namely, testing the joint
effect of a set of single nucleotide variants (SNVs) on a
genomic region, a functional unit (e.g., a gene) or a functional
pathway. The advantage of the joint association test over
the single-locus analysis lies in the fact that, by combining
multiple SNVs, not only the association information is ag-
gregated but also the number of tests is greatly reduced.
The joint association tests can be briefly classified into two
categories: burden tests and non-burden tests. Burden tests
first summarize multiple rare variants into a univariate genetic
score, and then test the association of the summary score
with the disease phenotype.(Morgenthaler and Thilly, 2007;
Li and Leal, 2008; Madsen and Browning, 2009; Lin and Tang,
2011). Burden tests often assume the effect of the multiple
variants have similar magnitude and direction. Non-burden
tests, on the other hand, can take into account of the effect
heterogeneity within the SNV-set, by considering the effect
of the multiple variants as random effects or function of
genomic position.(Neale et al., 2011; Wu et al., 2011; Luo
et al., 2012). Among non-burden methods, sequence kernel
association test (SKAT) shares many nice computational and
asymptotic properties with the variance component score test,
and has been very popularly used(Wu et al., 2011).
Most of existing joint association tests are parametric-
based methods, which often rely on certain assumptions (e.g.,
a normal distribution assumption). When the assumptions are
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2violated, they are subjected to power loss or an inflated type I
error. Moreover, there lacks the development of new methods
for the multivariate analysis of sequencing data, especially
when the phenotype follows different different distributions
(e.g., some phenotypes are binary while the others are con-
tinuous). The study of multiple phenotypes is important in
biomedical research. Many studies collect multiple biochemi-
cal measurements related to a disease of interest. These mul-
tiple measurements evaluate different aspects of the disease,
and thus better reflect the underlying biological mechanism of
the disease. It also becomes popular for human genetic studies
to collect and study multiple disease phenotypes. For instance,
studies have identified common gene variants contributed
to co-morbidity of substance dependence(Dick and Agrawal,
2008).
To achieve these goals, we propose a Generalized Similarity
U test, referred to as GSU. We use two different similarity
measurements to summarize genetic information and pheno-
typic information, and then form a test under the weighted
U framework. We derive the asymptotic distribution of the
test statistic and implement the new method in R. The
proposed method has several remarkable features: 1) it is non-
parametric and is thus robust to phenotype distributions; 2) it
can handle multiple different phenotypes (e.g., a combination
of binary and continuous phenotypes); 3)it has a nice statis-
tical property and performs well under small sample sizes.
Simulation studies are conducted to compare the type 1 error
and the power of our method with those of several commonly
used methods. Finally, we applied the new method to the
Dallas Heart Study to test the association of 4 candidate genes
with 5 metabolic-related phenotypes.
2. Generalized Similarity U
2.1 Weighted U Statistic
Suppose that n subjects are sequenced in a study, where
we are interested in testing the association of L phenotypes
(yi,l, 1 6 i 6 n, 1 6 l 6 L) with M genetic variants (gi,m,
1 6 i 6 n, 1 6 m 6 M). For each subject i, we observe a
vector of phenotypes yi ( yi = (yi,1, yi,2, · · · , yi,L) ) and a
vector of genotypes gi ( gi = (gi,1, gi,2, · · · , gi,M )). In the
special case when L = 1 (or M = 1), it is simplified to a
univariate analysis (or a single-locus analysis). When L > 1,
it extends to a multivariate analysis. In GSU, we allow
multiple phenotypes to be of different types (e.g., continuous
or categorical), and do not assume any distribution of
phenotypes. The number of genetic variants M and the
number of phenotypes L can be larger than the sample size.
For example, the genetic data can be sequencing data (high
demensional genotypes) and the phenotype data can be
imaging data (high demensional phenotypes).
Given the phenotypes and the genotypes for the subjects i
and j ,we first define their phenotype similarity Si,j by,
Si,j = h(yi, yj),
and define their genetic similarity Ki,j by,
Ki,j = f(gi, gj).
The similarity measurements h(· , · ) and f(· , · ) defined above
can be of a general form as long as they satisfy the fi-
nite second moment condition (i.e.,E(h2(Y1, Y2)) < ∞ and
E(f2(G1, G2)) < ∞ ). We further center the phenotype
similarity by,
S˜i,j = h˜(yi, yj)
= h(yi, yj)− E(h(yi, Yj))
−E(h(Yi, yj)) + E(h(Yi, Yj)), (1)
and center the genetic similarity, K˜i,j = f˜(gi, gj), in a similar
manner. The generalized similarity U (GSU) is then defined
as the summation of the centered phenotype similarities
weighted by the centered genetic similarities,
U =
1
n(n− 1)
∑
i 6=j
K˜i,jS˜i,j , (2)
where the K˜i,j is considered as the weight function and the
S˜i,j is considered as the U kernel. In our definition of GSU,
the role of genetic similarity and phenotype similarity are
interchangeable. In other words, we can also treat S˜i,j as the
weight function and K˜i,j as the U kernel.
2.2 Similarity Measurement
The choices for the phenotype similarity h(· , · ) and the
genetic similarity f(· , · ) are flexible. According to different
types of genetic variants and the purpose of the analysis,
we can choose different types of phenotype similarities and
genetic similarities.
For the categorical SNVs data, we can use either the IBS
function or the weighted IBS function to measure the genetic
similarity(Lynch and Ritland, 1999). Assuming the genetic
variants (gi,m, 1 6 i 6 n, 1 6 m 6 M) are coded as 0, 1 and
2, respectively for AA, Aa and aa, we can define the IBS-based
genetic similarity between subjects i and j as,
KIBSi,j =
1
2M
M∑
m=1
2− |gi,m − gj,m|.
Alternatively, we can use a weighted-IBS (wIBS) genetic
similarity to emphasize the effects of rare variants,
KwIBSi,j =
M∑
m=1
wm(2− |gi,m − gj,m|)
Υ
,
where wm represents the weight for them-th SNV in the SNV-
set, and Υ is a scaling constant, defined as Υ = 2
∑M
m=1 wm.
wm is usually defined as a function of minor allele frequency
(MAF, denoted as γm). For example, we can define the
weight wm as wm = 1/
√
γm(1− γm) . When the genetic
data are count data or continuous data, we can use other
forms of f(· , · ) to measure genetic similarity (e.g., euclidian
distance based similarity), which, we will leave for further
investigations.
For phenotype similarity, we define a unified measurement
for both categorical and continuous phenotypes based on a
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normal quantile. For each phenotype, yl (1 6 l 6 L), we
define the corresponding normal quantile by,
qi,l = Φ
−1((rank(yi,l)− 0.5)/n),
where rank(· ) corresponds to the rank of the phenotype value
yi,l. When there are ties, we assign the averaged rank. Φ
−1(· )
is the inverse cumulative density function for a standard
normal distribution. We can then calculate the Euclidian
Distance (ED) based phenotype similarity between subjects i
and j by,
SEDi,j = exp(−
L∑
l=1
ωl(qi,l − qj,l)2),
where ωl represents the weight for the l-th phenotypes given
based on prior knowledge. If there is no prior knowledge, we
can use an equal weight, ωl = 1/L. The ED-based phenotype
similarity can be easily modified to take the correlation among
the phenotypes into account,
SEDi,j = exp
(
− 1
L
(qi − qj)TΓ(qi − qj)
)
,
where qi = (qi1, · · · , qiL)T . Γ can be chosen to reflect the
correlations among the phenotypes. For example, we can
define Γ as,
Γ = (
1
n
n∑
i=1
qiq
T
i )
−1.
Other than the ED based phenotype similarity, we can define
the phenotype similarity using cross product(Tzeng et al.,
2009). The types of phenotype similarity or genetic similarity
can be chosen based on different purposes, which may influ-
ence the power of the method. For simplicity, we used an
ED-based phenotype similarity in this paper.
2.3 Hypothesis testing
Based on the definition of the centered similarity, we can
show that E(f˜(Gi, Gj)) = 0 and E(h˜(Yi, Yj)) = 0 (Appendix
A). Under the null hypothesis, when the genetic variants are
not associated with multiple phenotypes, we have E(U) = 0
(Appendix A). Under the alternative hypothesis, when the
genetic variants are associated with multiple phenotypes, we
expect that the phenotype similarity is concordant with the
genetic similarity. In other words, the positive phenotype
similarities are weighted heavier and the negative phenotype
similarities are weighted lighter, leading to a positive value
of U statistic. A statistical test can be formed to test the
association and its p-value can be calculated by P (U > Uobs),
where Uobs is the observed value of U . Tests based on
permutation or bootstrap can be implemented to obtain
the statistical significance. Nevertheless, both methods
are computationally expensive for high-dimensional data.
Therefore, we derive the asymptotic distribution of GSU to
assess the statistical significance of the association test.
By considering the genetic similarity as the weight func-
tion and the phenotype similarity as the U kernel, GSU
is a weighted U statistic(Gregory, 1977; Shapiro and Hu-
bert, 1979; O’Neil and Redner, 1993; Shieh, 1997; Lindsay
et al., 2008). More specifically, because its kernel satisfied
V ar(E(h˜(Y1, Y2)|Y2)) = 0 (Appendix A), GSU is a degener-
ated weighted U statistic. To derive the limiting distribution
of GSU, we can decompose the centered phenotype similarity
by,
h˜(y1, y2) =
∞∑
s=1
λsφs(y1)φs(y2),
where {λs} and {φs(· )} are eigenvalues and eigenfunctions of
the U kennel h˜(· , · ), and all the eigenfunctions are orthogonal,
ˆ
φs(y1)φs′(y1)dF (y1) =
{
0, if s 6= s′
1, if s = s′.
Similarly, we can decompose the centered genetic similarity
by,
f˜(Gi, Gj) =
∞∑
t=1
ηtϕt(g1)ϕt(g2).
We can then rewrite the GSU as,
U =
1
n− 1
∞∑
t=1
∞∑
s=1
sign(ηtλs)
(
1√
n
n∑
i=1
η?t (Gi)φ
?
s(Yi)
)2
− 1
n− 1
∞∑
t=1
∞∑
s=1
sign(ηtλs)
1
n
n∑
i=1
(η?t (Gi)φ
?
s(Yi))
2
,
where ϕ?t (Gi) = |ηt|0.5ϕt(Gi) and φ?s(Yi) = |λs|0.5φs(Yi)
(Appendix B).
Using the form above, we can show that the limiting
distribution of GSU is a weighted sum of independent chi-
square random variables. This is the result of theorem 1 below,
which is proved in Appendix B.
Theorem 1: Suppose E(h2(Y1, Y2)) < ∞,
E(f2(G1, G2)) < ∞, and Y ⊥ G. Let h˜(Y1, Y2) and
f˜(G1, G2) be the centered similarities as defined in (1).
Define U as U = 1
n(n−1)
∑
i 6=j f˜(Gi, Gj)h˜(Yi, Yj). Then,
nU
D−→ ∑∞t=1 ηt∑∞s=1 λs(χ2st − 1), where {χ2st} are
independent chi-square random variables with 1 degree
of freedom.
2.4 The power and sample size calculation
In this subsection, we derive the asymptotic distribution of
GSU under the alternative hypothesis, and provide power
and sample size calculations for sequencing association
studies.
Assume under the alternative hypothesis
that E(f˜(G1, G2)h˜(Y1, Y2)) = µ > 0 and
V ar(f˜(G1, G2)h˜(Y1, Y2)|(G2, Y2)) = ζ1 > 0 , where µ
measures the strength of the association. It is easy to show
that GSU is an unbiased estimator of µ,
E(U) =
1
n(n− 1)
∑
i 6=j
E(f˜(Gi, Gj)h˜(Yi, Yj)) = µ.
Using the Hoeffding projection, we can show that GSU
asymptotically follows a normal distribution, with mean µ
and variance 4ζ1/n. This is the result of Theorem 2, which is
proved in Appendix C.
4Theorem 2: Let h˜(Y1, Y2) and f˜(G1, G2) be the cen-
tered similarities as defined in (1). Suppose Y is asso-
ciated with G, and the following conditions are satisfied:
E(f˜(G1, G2)h˜(Y1, Y2)) = µ > 0, V ar(f˜(G1, G2)h˜(Y1, Y2)) =
ζ0 < ∞, and V ar(f˜(G1, G2)h˜(Y1, Y2)|(G2, Y2)) = ζ1 > 0.
Define U as U = 1
n(n−1)
∑
i 6=j f˜(Gi, Gj)h˜(Yi, Yj). Then,√
n(U − µ) D−→ N(0, 4ζ1).
The power of GSU at the significance level α can be
calculated by,
P{nU > q1−α}
=P
{√
n(U − µ)
2
√
ζ1
>
q1−α − nµ
2
√
nζ1
}
=Φ(
nµ− q1−α
2
√
nζ1
),
where q1−α is the 1−α quantile for ∑∞t=1 ηt∑∞s=1 λs(χ2st−1)
and Φ(· ) is the CDF of a standard normal distribution. The
sample size required to achieve power β can be calculated by
solving Φ(
nµ−q1−α
2
√
nζ1
) > β. By denoting Zβ as the β quantile
for a standard normal distribution, the required sample size
is given by,
n = min
n∈N
n : n >
(
Zβ
√
ζ1 +
√
Z2βζ1 + µq1−α
)2
µ2
 .
2.5 Computation and implementation
Let S = {Si,j}n×n and K = {Ki,j}n×n be the matrix form of
the phenotype similarity and genetic similarity, the centered
similarity matrices S˜ and K˜ can be obtained by,
S˜ = (I − J)S(I − J),
K˜ = (I − J)K(I − J),
where I is an n-by-n identity matrix, and J is an n-by-n matrix
with all elements being 1/n (Appendix D). Then GSU can be
expressed as,
U =
1
n(n− 1)
∑
i6=j
K˜i,j S˜i,j .
In this form, U can be viewed as a sum of the element-wise
product of the two matrices, K˜0 and S˜0, which are obtained
by assigning 0 to the diagonal elements of matrices K˜ and
S˜. We then use matrix eigen-decomposition to approximate
the eigen-values in function decomposition. Let {λ˜s} and
{η˜t} respectively be the eigen-values for matrices K˜0 and S˜0
(Appendix E), the limiting distribution of U is given by,
nU ∼
n∑
t=1
η˜t
n
n∑
s=1
λ˜s
n
(χ2st − 1),
where {χ2st} are independent chi-square random variables
with 1 degree of freedom. The p-value can be calculated by us-
ing the Davies’ method (Davies, 1980), the Liu’s method(Liu
et al., 2009) or the Kuonen’s method(Kuonen, 1999).
3. Simulation study
3.1 Simulation method
To mimic real genetic structure, we used genetic data from
the 1000 Genome Project(Abecasis et al., 2010). Based on
the genetic data, we then simulated phenotype values. In
particular, we used a 1Mb region of the genome (Chromosome
17: 7344328-8344327) from the 1000 Genome Project. For
each simulation replicate, we randomly chose a 30kb segment
from the 1Mb region and formed a SNV-set for the analysis.
From the SNV-set, we set a proportion of the SNVs as causal.
A number of individuals were randomly chosen from the total
1092 individuals as the simulation sample to study the perfor-
mance of the methods. To investigate the robustness against
different phenotype distributions, we simulated three types
of phenotypes: a binary-distributed phenotype, a Gaussian-
distributed phenotype and a Cauchy-distributed phenotype.
The binary-distributed phenotype was simulated by using a
logistic regression model,
logit(P (Yi = 1)) = µ+G
T
i β,
where Yi and Gi were the phenotype value and the genotype
vector (coded as 0, 1, and 2) for the i-th individual, respec-
tively. β were the effects of the SNVs, which were sampled
from a uniform distribution with a mean of µβ and a variance
of σ2β . The Gaussian-distributed phenotype was simulated by
using the linear regression model,
Yi = µ+G
T
i β + εi, εi ∼ N(0, σ2).
The Cauchy-distributed phenotype mimicked a situation in
which the continuous phenotype had more extreme values
(i.e. heavy-tailed), and was simulated by using the following
model,
Yi ∼ cauchy(ai, b), ai = µ+GTi β,
where ai and b are the location parameter and the scale
parameter of the Cauchy distribution, respectively.
Two sets of simulation were performed. In simulation I,
we considered a single phenotype, while in simulation II, we
considered multiple-phenotypes.
3.1.1 Simulation I Setting. Under the null, the models
were simulated by setting µβ = 0 and σ
2
β = 0, and by
varying the sample size from 50 to 500 (i.e. 50, 100, 200 and
500). Under the alternative, two sets of disease models were
simulated:
(1) Set µβ = 0 and σ
2
β > 0 so that half of the causal SNVs
were deleterious and the other half were protective.
(2) Set µβ > 0 and σ
2
β > 0 so that majority of the causal
SNVs were deleterious.
The details of the simulation setting can be found in Table
S1 of Supplementary Materials.
3.1.2 Simulation II Setting. Two sets of models were sim-
ulated:
(1) Assume the multiple phenotypes follow the same distri-
bution. In particular, we simulated 3 binary-distributed
phenotypes (BBB), 3 Gaussian-distributed phenotypes
(GGG), and 3 Cauchy-distributed phenotypes (CCC).
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(2) Assume the multiple phenotypes follow different dis-
tributions. In particular, we simulated 3 pheno-
types with 2 binary-distributed phenotypes and 1
Gaussian-distributed phenotype (BBG), 3 phenotypes
with 1 binary-distributed phenotypes and 2 Gaussian-
distributed phenotypes (BGG), and 3 phenotypes with
1 binary-distributed phenotype, 1 Gaussian distributed
phenotype and 1 Cauchy distributed phenotype (BGC).
Similar as the simulation I, for the null model, we set µβ = 0
and σ2β = 0 . For the alternative models, we set µβ = 0 and
σ2β > 0 , and allowed the multiple phenotypes to be influenced
by different sets of causal SNVs. The details of the simulation
setting were described in Table S2 of Supplementary Materi-
als.
3.2 Simulation result
We evaluated the performance of GSU by comparing it with
three existing methods, SKAT(Wu et al., 2011), AdjSKAT
and SKATO(Lee et al., 2012). For each simulation, we created
1000 simulation replicates to evaluate type 1 error and power.
For GSU, we used the wIBS-based genetic similarity and ED-
based phenotype similarity to construct the U statistic. To
be consistent, we used the same weighted IBS to construct
the kernel for SKAT. Because neither AdjSKAT nor SKATO
had an option for a weighted IBS kernel, we used the default
kernel, the weighted linear kernel, when applying these two
methods. SKAT, AdjSKAT and SKATO are designed for
univariate analysis. To consider multiple phenotypes, we chose
the most significant p-value from the univariate analysis,
and then adjust for multiple tests by using the Bonferroni
correction.
3.2.1 Result for Simulation I. The type I error rates of
the 4 methods are summarized in Table 1. GSU had a well-
controlled type I error, regardless of phenotype distributions
and sample sizes. Neverthless, SKAT, AdjSKAT and SKATO
had inflated type I error rates (ranging from 0.101 to 0.19)
for the Cauchy-distributed phenotype. When the sample size
was small (e.g., 50 or 100), SKAT and SKATO also had con-
servative type I error (e.g., 0.001) for the binary-distributed
phenotype.
The power comparison is summarized in Figures 1 and 2.
For the disease model where half of the causal SNVs were dele-
terious (Figure 1), GSU had higher power than other methods
for various sample sizes ranging from 50 to 500. For in-
stance, in the simulation with binary phenotype and a sample
size of 50, GSU (power=0.346) attained much higher power
than AdjSKAT (power=0.114), SKATO (power=0.057), and
SKAT (power=0.024). Similarly, for the Gaussian-distributed
phenotype, GSU had the highest power among the four
methods, and the three SKAT-based methods had similar
performance. For the Cauchy-distributed phenotype, where
the distribution assumption was violated, the power of the
SKAT-based methods remained similar as the sample sizes
increased, while GSU had increased power as the sample size
increased. For the second disease model in which a majority of
the SNVs were deleterious (Figure 2), we observed the same
conclusion, i.e., GSU had highest power regardless of sample
sizes and phenotype distributions.
Table 1
Type I error comparison for the univariate analysis
Sample size Method Distribution
Binary Gaussian Cauchy
50 SKAT 0.001 0.030 0.122
SKATO 0.021 0.041 0.101
AdjSKAT 0.054 0.028 0.123
GSU 0.058 0.046 0.051
100 SKAT 0.014 0.028 0.149
SKATO 0.035 0.038 0.120
AdjSKAT 0.063 0.027 0.139
GSU 0.046 0.050 0.053
200 SKAT 0.023 0.040 0.155
SKATO 0.024 0.042 0.140
AdjSKAT 0.043 0.042 0.156
GSU 0.057 0.048 0.045
500 SKAT 0.039 0.055 0.190
SKATO 0.052 0.056 0.158
AdjSKAT 0.049 0.053 0.180
GSU 0.038 0.046 0.043
Intuitively, as a semi-parametric model, SKAT should have
comparable power with GSU. The reason for the advantage
of GSU lies in the form of test statistics. The score test of
SKAT utilizes both diagonal terms and off-diagonal terms
of the similarity matrix. When the null model gives the
same predicted values (i.e., no covariates), the diagonal terms
essentially provide no additional information with regard to
association, while adding more variation (i.e., noise) to the
score statistic. Meanwhile, GSU utilizes only the off-diagonal
terms. When the sample size is small, the influence of diagonal
terms will be significant, which is why we observed the higher
power of GSU over SKAT. When the sample size becomes
larger, the off-diagonal terms will dominate, and the difference
of power of two methods becomes smaller.
3.2.2 Result for Simulation II. The type I error rates for
the multivariate analysis are summarized in Table 2. Similar
to the results of the univariate analysis, GSU can correctly
control type I error at the level of 0.05 (Table 2), while
the other three methods had inflated type I error when the
distribution assumption was violated (e.g., CCC and BGC).
When the distribution assumption was satisfied, AdjSKAT
correctly controlled the type 1 error. SKAT and SKATO,
however, had conservative type I error rates for small sample
sizes (50 and 100), especially when the multiple phenotypes
comprised of binary-distributed phenotypes (e.g., BBB, BBG
and BGG).
The power comparison of four methods under the two
disease models is summerized in Figures 3 and 4. For the dis-
ease model where the multiple phenotypes followed the same
distribution, GSU had higher power than the three SKAT-
based methods (Figure 3). For simulations with BBB phe-
notypes and GGG phenotypes, GSU attained higher power
than the other three methods when the sample size was
50, and obtained substantial power improvement as sample
sizes increased. For the simulation with CCC phenotypes, we
6Figure 1. Power comparison for univariate analysis when a majority of causal SNVs are deleterious
Figure 2. Power comparison for univariate analysis when half of causal SNVs are protective and the other half of causal
SNVs are deleterious
also observed substantial power improvement of GSU than
the other three methods as sample size increased. Yet, the
power of the three SKAT-based methods were higher than
that of GSU when the sample size was 50. This can be
explained by the inflated type 1 error rates of the SKAT-based
methods for the Cauchy-distributed phenotypes (Table 2).
Similarly, for disease models with a combination of different
types of phenotype distribution (i.e., BBG, BGG, and BGC),
GSU had higher power than SKAT, SKATO and AdjSKAT,
regardless of sample size and phenotype distributions (Figure
4).
Comparing with univariate analysis in simulation I, GSU
had further power improvement by considering the association
of multi-phenotype in one single test. The three SKAT-based
methods, on the other hand, performed multiple univariate
analyses with Bonferroni correction. Under the alternative,
the multiple phenotypes are correlated to each other. The
univariate analysis with Bonferroni correction is subject to
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Table 2
Type I error comparison for multivariate analysis
Sample size Method Same Distr. a Diff Distr.
BBB GGG CCC BBG BGG BGC
50 SKAT 0.002 0.028 0.232 0.008 0.021 0.097
SKATO 0.019 0.027 0.207 0.016 0.024 0.085
AdjSKAT 0.046 0.028 0.237 0.049 0.040 0.113
GSU 0.057 0.047 0.045 0.034 0.043 0.056
100 SKAT 0.001 0.023 0.295 0.011 0.013 0.122
SKATO 0.025 0.039 0.260 0.025 0.036 0.117
AdjSKAT 0.055 0.025 0.290 0.059 0.042 0.135
GSU 0.048 0.047 0.044 0.051 0.059 0.058
200 SKAT 0.020 0.048 0.325 0.033 0.020 0.134
SKATO 0.030 0.058 0.288 0.035 0.036 0.118
AdjSKAT 0.059 0.046 0.319 0.064 0.038 0.136
GSU 0.050 0.047 0.049 0.058 0.056 0.043
500 SKAT 0.044 0.035 0.364 0.035 0.04 0.166
SKATO 0.054 0.036 0.315 0.038 0.047 0.156
AdjSKAT 0.06 0.038 0.342 0.041 0.049 0.172
GSU 0.045 0.054 0.044 0.046 0.039 0.062
aB, G, and C represent Binary-distributed, Gaussian-distributed, and Cauchy-distributed pheno-
types, respectively.
power loss without considering the correction structure of
multiple phenotypes. Meanwhile, GSU can take the correla-
tion structure into account when constructing the phenotype
similarity, and therefore attained higher power than the other
three methods.
3.3 Computational Efficiency
We compared the computational efficiency of R-based GSU
with SKAT, SKATO and AdjSKAT. We found GSU attained
highest computational efficiency among four methods. For
example, for the multivariate analysis of BBG phenotype with
a sample size of 500 on 1000 simulation replicates, SKAT,
SKATO and AdjSKAT took 5 (4320s), 16 (13686s) and 25
(20890s) times longer than GSU (849s), using a personal
computer with 2.3GHz CPU and 4G memory. The detailed
computational efficiency comparison of four methods for ana-
lyzing data with various distributed phenotypes and different
sample sizes is given in Table S3 of Supplementary Materials.
Although the comparisons were made under simulation
setting, they represent general scenarios in practice. All four
methods need to spend substantial time on eigen decomposi-
tion in the final step of calculating asymptotic distribution.
For multivariate analysis, GSU performs the eigen decompo-
sition once for all phenotypes, while SKAT-based methods
need to perform the eigen decomposition for each phenotype.
Moreover, if the link function is not identity link, iterative
estimation for null model and additional large matrix multi-
plication and decomposition are required before the final eigen
decomposition, which will also increase the computational
burden of SKAT-based methods.
4. Application to the Dallas Heart Study
To evaluate the performance of GSU on real data, we applied
it to the Dallas Heart Study (DHS) sequence data(Ahituv
et al., 2007) and compared the result of GSU with those
of three SKAT-based methods. The DHS sequencing data
is comprised of 4 genes, ANGPTL3, ANGPTL4, ANGPTL5
and ANGPTL6. After completing the quality control (e.g.,
removing SNVs with high missing rate), 230 SNVs (54 SNVs,
63 SNVs, 61 SNVs, and 52 SNVs were from ANGPTL3,
ANGPTL4, ANGPTL5 and ANGPTL6, respectively) and
2598 subjects remained for the analysis. In the real data
analysis, we were interested in testing the association of the
SNVs in these genes with multiple metabolic-related phe-
notypes, including obesity (dichotomized from BMI using a
cut-off of 35), cholesterol, high-density lipoprotein cholesterol
(HDL), low-density lipoprotein cholesterol (LDL) and very-
low-density lipoprotein cholesterol (VLDL).
In order to consider the potential confounding effects of
age, gender and race, we adjusted these covariates in the
analysis and used the residuals to build phenotype similarity
for GSU. Because the three SKAT-based methods cannot
directly analyze multiple phenotypes, we obtained smallest p-
values from the univariate analysis of all phenotypes and then
used the Bonferroni correction to determine whether there
was a significant association. The results are summarized
in Table 3. Because all 4 genes were metablolic candidate
genes, we first combined SNVs in the 4 genes into a single
SNV-set. For the joint analysis of 4 genes, GSU could de-
tect a significant association of 4 genes with 4 metabolic-
related phenotypes (p-value=0.028), while SKAT, SKATO
and AdjSKAT did not detect the association. For further
exploration, we analyzed each gene separately and tested its
8Figure 3. Power comparison for the multivariate analysis when the multiple phenotypes follow the same type of distribution
Figure 4. Power comparison for the multivariate analysis when the multiple phenotypes follow the different types of
distributions
association with 4 metabolic-related phenotypes. By using
GSU, we found a marginal association of ANGPTL4 with
the multiple phenotypes(p-value=0.057).
5. Discussion
Driven by recent developments in sequencing technologies
and the common-diseases-rare-variants hypothesis, sequenc-
ing studies are now emerging as a major study design for the
genetic association of complex diseases. Yet, the uniqueness
of sequencing data, including low MAF and high dimension-
ality, pose daunting challenges to statistical analysis. The
conventional methods, such as a single-locus analysis using
logistic regression, had low power for sequencing data anal-
ysis. Instead, joint association analysis, or SNV-set analysis,
is becoming popular due to its ability to increase power and
reduce multiple testing. Although the existing joint associa-
tion methods have nice features and are easy to use, they also
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Table 3
The multivariate analysis of 4 metabolic-related phenotypes in the DHS study
Gene Rare variants P-value a
GSU SKAT AdjSKAT SKATO
ANGPTL3 54 0.300 0.083 0.071 0.112
ANGPTL4 63 0.057 0.079 0.086 0.155
ANGPTL5 61 0.075 0.046 0.073 0.107
ANGPTL6 52 0.297 0.059 0.065 0.101
ALL 230 0.028 0.250 0.174 0.245
aMultiple phenotypes considered in the analysis include BMI, cholesterol, HDL, LDL and VLDL.
For SKAT-based methods, each p-value listed in the table is the smallest p-value from 5 univariate
analysis, where the Bonferroni corrected significance level should be 0.05/5.
have certain limitations. For example, most of burden tests
assume homogeneous effects within the SNV-set, which may
not reflect the true underlying disease models. Besides burden
tests, most of the existing methods are parametric or semi-
perimetric, which often assume certain distributions of the
phenotypes and mode of inheritance. When the assumptions
are violated, the results can be unreliable.
To overcome these limitations, we have proposed a gen-
eralized similarity U test for multivariate analysis of differ-
ent types of phenotypes. We conducted extensive simula-
tion studies using data from the 1000 Genome Project and
compared the performance of GSU with that of three other
popular methods: SKAT, AdjSKAT and SKATO. For all
of the simulation scenarios, including single phenotype with
various distributions, and multiple phenotypes with various
combinations of phenotype distribution, GSU outperformed
the other three methods in terms of robust type I error and
higher power. Although the simulation results depend on the
simulation settings, and should always be interpreted in the
context of the simulation setting, we believe the results reflect
the advantage of GSU in a broader sense, because 1) the
genetic data used in the simulation comes from the 1000
Genome Project, which reflects the LD pattern and the allelic
frequency distribution in the general population; and 2) we
simulated a wide range of disease models to mimic common
disease scenarios.
In recent years, U-statistic-based methods have been pop-
ularly used in genetic data analysis, and have shown their
robustness and flexibility for analyzing genetic data(Schaid
et al., 2005; Zhang et al., 2010; Wei et al., 2013). GSU
is a general framework based on similarity measurements.
Although in this paper we used the weighted-IBS to calculate
genetic similarity, other forms of genetic similarity can also
be used. For the weighted-IBS similarity, we can modify the
weights (i.e., the original weight wm = 1/
√
γm(1− γm))
to reflect the importance of each SNV. Besides IBS-based
similarity, we can also use distance-transformed similarity
to model the effect in a nonlinear way. For example, we
can use the Euclidean-Distance-based similarity, KEDi,j =
exp(−∑Mm=1 wm(gi,m−gj,m)2). In this paper, we have focused
on the analysis of categorical sequencing data (i.e, SNV data).
By using appropriate genetic similarity measurements, GSU
can easily be extended to analyze other types of genetic
data, such as count data (CNV data) and continuous data
(expression data).
The flexibility of GSU also comes from the construction
of the phenotype similarity. By using phenotype similarity,
GSU can analyze not only a single phenotype, but also
multiple phenotypes following different distributions. Many
genetic studies collect multiple secondary phenotypes, or use
intermediate biomarkers, to study complex diseases. By con-
sidering multiple phenotypes that measure the different as-
pects of underlying diseases, the power of association analysis
can be potentially improved (Zhang et al., 2010; Liu et al.,
2009; Maity et al., 2012). Nevertheless, few methods have
been developed for multivariate analysis of sequencing data.
Methods were recently developed for multivariate analysis of
common genetic variants, but relies on the normal assumption
for the phenotype distribution (Maity et al., 2012). GSU
is developed for both univariate and multivariate analysis
of sequencing data. It is distribution-free and can analyze
multiple phenotypes with a combination of different types of
phenotype. Nevertheless, similar as all other non-parametric
tests, it is not straightforward for GSU to perform covariate
adjustment. One possible solution is to adopt the idea of
covariate adjustment in regression, and include covariates
when we calculate the centered similarity (e.g., S˜ = (I −
X(XTX)−1XT )S(I −X(XTX)−1XT )).
Supplementary Materials
Supplementary Materials are available with this paper at the
Biometrics website on Wiley Online Library.
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Appendix A: Centered Similarity
By the following definition of centered similarity,
h˜(y1, y2) = h(y1, y2)− E(h(y1, Y2))
−E(h(Y1, y2)) + E(h(Y1, Y2))
we can obtain conditional expectation for the centered phe-
notype similarity,
E(h˜(Y1, Y2)|Y1) = E(h(Y1, Y2|Y1))− E(h(Y1, Y2|Y1))
−E(h(Y1, Y2)) + E(h(Y1, Y2))
= 0.
Therefore, we have E(h˜(Y1, Y2)) = 0 and
V ar(E(h˜(Y1, Y2)|Y1)) = 0. Using the same argument,
we can have the same result for the centered genetic
similarity.
Under the null hypothesis, when the genetic similarities are
independent of the phenotype similarities, we have,
E(U) =
1
n(n− 1)E(
∑
i6=j
f˜(Gi, Gj)h˜(Yi, Yj))
=
1
n(n− 1)
∑
i6=j
E(f˜(Gi, Gj))E(h˜(Yi, Yj))
= 0.
Appendix B: Proof of Theorem 1
We can decompose the centered phenotype similarity by,
h˜(y1, y2) =
∞∑
s=1
λsφs(y1)φs(y2),
where {λs} and {φs(· )} are eigenvalues and eigenfunctions of
the kennel h˜(· , · ).
Because of the orthogonality of {φs(· )} , we have
E(h˜(Y1, Y2)φs′(Y2)|Y1)
=
ˆ
h˜(Y1, y2)φs′(y2)dF (y2)
=
∞∑
s=1
λsφs(Y1)
ˆ
φs(y2)φs′(y2)dF (y2)
=λs′φs′(Y1).
We showed E(h˜(Y1, Y2)×1|Y1) = 0×1 in Appendix A, which
forced φ1(· ) = 1 and λ1 = 0 to be an eigenfunction-eigenvalue
pair in the decomposition of h˜(· , · ). Again, because φ1(· ) is
orthogonal with {φs(· )}s>1, for s > 1, we have
Eφs(Y1) =
ˆ
φs(y1)× 1dF (y1)
=
ˆ
φs(y1)φ1(y1)dF (y1)
= 0.
Using the same argument, we have the corresponding results
for the decomposition of the centered genetic similarity:
f˜(Gi, Gj) =
∞∑
t=1
ηtϕt(g1)ϕt(g2).
Then, {
Eφs(Y ) = 0, ∀ s > 1
Eϕt(G) = 0 ∀ t > 1.
(Ax.1)
Using the function decomposition, we can write GSU as,
U =
1
n(n− 1)
∑
i 6=j
f˜(Gi, Gj)h˜(Yi, Yj)
=
1
n(n− 1)
∑
i 6=j
∞∑
t=1
ηtϕt(Gi)ϕt(Gj)
∞∑
s=1
λsφs(Yi)φs(Yj)
=
1
n(n− 1)
∞∑
t=1
ηt
∞∑
s=1
λs
∑
i6=j
ϕt(Gi)ϕt(Gj)φs(Yi)φs(Yj)
=
1
n− 1
∞∑
t=2
ηt
∞∑
s=2
λs
(
1√
n
n∑
i=1
ϕt(Gi)φs(Yi)
)2
− 1
n− 1
∞∑
t=2
ηt
∞∑
s=2
λs
1
n
n∑
i=1
(ϕt(Gi)φs(Yi))
2
=
1
n− 1
∞∑
t=2
∞∑
s=2
sign(ηtλs)
(
1√
n
n∑
i=1
η?t (Gi)φ
?
s(Yi)
)2
− 1
n− 1
∞∑
t=2
∞∑
s=2
sign(ηtλs)
1
n
n∑
i=1
(η?t (Gi)φ
?
s(Yi))
2
,
where ϕ?t (Gi) = |ηt|0.5ϕt(Gi) and φ?s(Yi) = |λs|0.5φs(Yi).
Under the null hypothesis, genotype (Gi) is independent of
phenotypes (Yi). Therefore, for s > 1 and t > 1,
E(η?t (G1)φ
?
s(Y1))
=|ηt|0.5Eϕt(G1)|λs|0.5Eφs(Y1)
=0, (Ax.2)
and
E(η?t (G1)φ
?
s(Y1)η
?
t′(G1)φ
?
s′(Y1))
=|ηtλsηt′λs′ |0.5E(ϕt(G1)ϕt′(G1))E(φs(Y1)φs′(Y1))
=
{
|ηtλs|, if s = s′and t = t′
0, otherwise.
(Ax.3)
Therefore, for any finite subset ∆ of {(s, t)}s>1,t>1,{
1√
n
∑n
i=1 η
?
t (Gi)φ
?
s(Yi)
}
(s,t)∈∆
converges to a multivariate
normal distribution by using results from equation Ax.2,
equation Ax.3 and multivariate CLT.
Additionally, we can show that,∑
s>1,t>1
E(η?t (G1)φ
?
s(Y1))
2
=
∑
s
|λs|
∑
t
|ηt|
<∞.
Under the condition
∑
s>1,t>1 E(η
?
t (G1)φ
?
s(Y1))
2 < ∞, the
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countable sequence of function {η?t (· )φ?s(· )} is a Donsker
class(van der Vaart and Wellner, 2000). Therefore, the em-
pirical process, 1√
n
∑n
i=1 η
?
t (Gi)φ
?
s(Yi), converges weakly to
the Gaussian process Zs,t with mean zero and covariance
function,
cov(Zs,t, Zs′,t′) = E(η
?
t (G1)φ
?
s(Y1)η
?
t′(G1)φ
?
s′(Y1))
=
{
|ηtλs|, if s = s′and t = t′
0, otherwise.
With this uniform convergence (for all s > 1 and t > 1), we
can show that,
nU
D−→
∞∑
t=2
∞∑
s=2
sign(ηtλs)(Zs,t)
2
−
∞∑
t=2
∞∑
s=2
sign(ηtλs)|ηtλs|
=
∞∑
t=1
ηt
∞∑
s=1
λs(χ
2
st − 1),
where χ2st are i.i.d chi-squared random variables with a d.f. of
1.
Appendix C: Proof of Theorm 2
To simplify the notation, we denote X = (Y,G) and
u(X1, X2) = f˜(G1, G2)h˜(Y1, Y2). GSU can then be rewritten
as:
U =
1
n(n− 1)
∑
i6=j
u(Xi, Xj).
Define a centered kernel u˜(x1, x2) by:
u˜(x1, x2) = u(x1, x2)− u1(x1)− u1(x2)− µ,
where u1(x) = E(u(X1, X2)|X1 = x).
We can decompose the GSU as follows:
U =
1
n(n− 1)
∑
i6=j
u(Xi, Xj)
=
1
n(n− 1)
∑
i6=j
(u˜(Xi, Xj) + u1(Xi) + u1(Xj)− µ)
=
1
n(n− 1)
∑
i6=j
u˜(Xi, Xj) +
2
n
n∑
i=1
(u1(Xi)− µ) + µ.
Thus,
√
n(U − µ) = 2√
n
n∑
i=1
(u1(Xi)− µ) +
√
n
n(n− 1)
∑
i 6=j
u˜(Xi, Xj).
Becuase E(u1(X)) = µ and V ar(u1(X)) = ζ1, the first term
converges to normal distribution by applying CLT:
2√
n
n∑
i=1
(u1(Xi)− µ) D−→ N(0, 4ζ1).
Then we need to show:
R =
√
n
n(n− 1)
∑
i 6=j
u˜(Xi, Xj)
p−→ 0.
This can be done by proving ER2 → 0, using the
fact that E(u˜(X1, X2)) = 0, V ar(u˜(X1, X2)) < ∞ and
E(u˜(X1, X2)|X1) = 0. In fact, by using the similar technique
in Appendix C, we can show that
√
nR asymptotically follows
the distribution of a weighted sum of independent chi-square
random variables.
Appendix D: Matrix Similarity
In the study sample, we can calculate the centered phenotype
similarity by:
h˜(yi, yj) = h(yi, yj)− 1
n
n∑
j=1
h(yi, yj)− 1
n
n∑
i=1
h(yi, yj)+
1
n2
∑
i,j
h(yi, yj).
Denote S˜i,j = h˜(yi, yj) and Si,j = h(yi, yj), the above
equation becomes:
S˜i,j = Si,j − 1
n
n∑
j=1
Si,j − 1
n
n∑
i=1
Si,j +
1
n2
∑
i,j
Si,j .
The equations can be written in a matrix form,
S˜ = S − JS − SJ + JSJ
= (I − J)S(I − J),
where S˜ = {h˜(yi, yj)}n×n, S = {h(yi, yj)}n×n, I =
{1{i=j}}n×n, and J = { 1n}n×n.
Similarly, the centered genetic similarity can also be written
in the matrix form:
K˜ = (I − J)K(I − J),
where K˜ = {f˜(gi, gj)}n×n, and K = {f(gi, gj)}n×n.
Appendix E: Limiting Distribution
In the actual computation, we will use a matrix eigen-
decomposition to obtain the eigenvectors as a finite-dimension
approximation of the eigenfunctions. For a matrix eigen-
decomposition, a computer algorithm usually gives the eigen-
value λs with the eigenvector φs, which satisfies
∑n
i=1 φ
2
s,i = 1
instead of 1
n
∑n
i=1 φ
2
s,i = 1. Therefore, using the eigenvalues
λ˜s and η˜t calculated from the matrix eigen-decomposition,
the limiting distribution of GSU is:
nU ∼
n∑
t=1
η˜t
n
n∑
s=1
λ˜s
n
(χ2st − 1).
.
